Systemic candida
Not recruitingStudy of Recombinant Interferon-Gamma 1b Combined with Standard Treatment for Patients with Candidemia: Safety and Effectiveness Evaluation
Study of Recombinant Interferon-Gamma 1b Combined with Standard Treatment for Patients with Candidemia: Safety and Effectiveness Evaluation
- Disease:Systemic candida
- Substances:Recombinant human interferon gamma 1B
The Netherlands- Participants:18–64 years · 65+ years
- Substances:Recombinant human interferon gamma 1B
- Sponsor:Radboud universitair medisch centrum Stichting











